NCT01829958View on ClinicalTrials.gov

Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy

NAActive, not recruitingINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Non Hodgkin Lymphoma (NHL)Diffuse Large B-cell Lymphoma (DLBCL)
Interventions
DRUG

rituximab

DRUG

prednisone

BEHAVIORAL

Geriatric Assessment

Trial Locations (8)

10065

Memorial Sloan Kettering Cancer Center, New York

10604

Memorial Sloan Kettering Westchester, Harrison

11553

Memorial Sloan Kettering Nassau, Uniondale

11570

Memorial Sloan Kettering Rockville Centre, Rockville Centre

11725

Memorial Sloan Kettering Commack, Commack

07920

Memorial Sloan Kettering Basking Ridge, Basking Ridge

07748

Memorial Sloan Kettering Monmouth, Middletown

07645

Memorial Sloan Kettering Bergen, Montvale

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT01829958 - Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy | Biotech Hunter | Biotech Hunter